Quantcast
 
Read Larry Connors' blogShort Term Trading Strategies


 

CHRISTMAS TRADING CRUCIAL FOR API'S HEALTH AND BEAUTY RETAIL

Thu. October 30, 2008; Posted: 12:15 AM
Stocks RSS
SYDNEY, Oct 30, 2008 (AsiaPulse via COMTEX) -- APHIF | Quote | Chart | News | PowerRating -- Australian Pharmaceutical Industries Ltd (API) (ASX:API) expects challenging retail conditions ahead but predicts continued earnings growth as it expands its chain of Priceline stores.

The drug distributor and pharmacy retailer today reported net profit of $A15.213 million ($US10.16 million) for the 12 months to August 31.

In its last prior full year report, to April 30, 2007, API reported a loss of $11.3 million, before a loss of $2.598 million in the four months to the end of August, 2007.

API chief executive Stephen Roche said today the second half of the year to August had been more difficult than the first.

"The performance was very pleasing, particularly in light of the slower retail trading environment and managing the implementation of the largest ever pharmaceutical pricing through the PBS Reforms in July and August," he said.

Mr Roche told an analysts briefing the company expects further earnings growth in the year ahead, but a challenging economic environment requires a continued focus in costs.

"We do need to wait for some significant measurements, i.e. Christmas, before we determine API's longer position," he said.

"We are absolutely clear on where we want to be in two years, and I can assure you it is better than we are now."

API is continuing its transfer of its company-owned Priceline stores to Priceline Pharmacy franchises, and plans to grow store numbers from the current 300 to 400 during 2010.

Priceline has undergone a rebranding to increase its focus on health products, and its new direction will prove more appealing to consumers, Mr Roche said.

API's overhaul of its supply chain and implementation of three major distribution centres in Melbourne, Sydney and Brisbane has progressed well, he said.

The Melbourne facility is expected to be operational by mid-2009, and when the restructure is completed in fiscal 2011 it will deliver at least $10 million in savings.

Annual savings from implementation will now be more than the initial estimate of $18 million, Mr Roche said.

Revenue in API's pharmacy division was up 22 per cent on the previous comparable period to $2.47 billion, but increases in transport costs of 15 per cent due to higher fuel and labor costs proved challenging, the company said.

API declared a final dividend of one cent fully franked to be paid per share on December 15.

Further outlook will be provided at the company's annual general meeting on January 20.

At 1400 AEDT API shares were up one cent at 52.5 cents.

(AAP)

For full details for APHIF click here.

    


More News:   Market Updates | Stock Alerts | All Trading News | Stock Index

Email
Print
Archives
Feedback
Email Article Link
Close X
Recipients email address
Your name
Your email
Add a note (optional)




Stocks RSS





Related News [APHIF]
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

Disclaimer:

The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.

It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.

The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403

© Copyright 2009 The Connors Group, Inc.


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2009 The Connors Group, Inc.